Granted Patent
B2
US 8,288,384 · App. 12/619,577 · Granted Oct 16, 2012
Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
Assignee:
Metabolex, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Abstract
Compounds and methods are provided for the treatment of, inter alia, Type II diabetes and other diseases associated with poor glycemic control. The compounds of the invention are orally active.
Claims (1)
1. A method of treating Type II diabetes, said method comprising administering to a subject in need of such treatment an effective amount of a compound that is that is 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine or a pharmaceutically acceptable salt thereof.
Assignments (4)
RELEASE OF SECURITY INTEREST
Recorded Aug 7, 2015
From: SILICON VALLEY BANK; OXFORD FINANCE LLC
To: CYMABAY THERAPEUTICS, INC.
Reel/Frame 036307/0406 →
SECURITY AGREEMENT
Recorded Nov 22, 2013
From: CYMABAY THERAPEUTICS, INC.
To: SILICON VALLEY BANK; OXFORD FINANCE LLC
Reel/Frame 031710/0508 →
CHANGE OF NAME
Recorded Nov 6, 2013
From: METABOLEX, INC.
To: CYMABAY THERAPEUTICS, INC.
Reel/Frame 031589/0193 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jan 12, 2010
From: CHEN, XIN; CHENG, PENG; CLEMENS, L EDWARD; JOHNSON, JEFFREY D; MA, JINGYUAN; MURPHY, ALISON; NASHASHIBI, IMAD; RABBAT, CHRISTOPER J; SONG, JIANGAO; WILSON, MARIA E; ZHU, YAN; ZHAO, ZUCHUN
To: METABOLEX INC.
Reel/Frame 023770/0649 →
Continuity (3)
Provisional Application
60877903
· Dec 28, 2006